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New Public Management,
neo-liberalism and the
capture of health activism
any community groups concerned with health
issues—women’s organisations, disease-oriented
patient support groups and older-citizens
organisations—were formed long before their designation as
‘consumer’ groups. Members of health groups founded in the
1960s and 1970s understood themselves as activists for social
change, not ‘consumers’. They challenged established models
of health care and mobilised to redress inequities of access to
care and inequalities of power between the medical profession
and the ‘lay’ population. The major campaign in this period
was for the establishment of universal health insurance.
The policy influence of the organised consumer movement
peaked in the decade from the mid-1980s, when access to the
policy table was provided for the first time under Labor
governments federally and in several states. In that period
both peak and disease-oriented health consumer groups
received increased funding from governments and were
integrated into mainstream policy processes. These gains,
however, came at a price: in exchange for recognition as
legitimate policy actors they came under mounting pressure to
moderate their activist role and to exclude systemic critique.
One of the major sources of pressure on health policy actors
was the New Public Management (NPM) reform program,
based on neo-liberal ideology. By defining health care
provision as a market exchange, with ‘choice’ as the central
value, neo-liberal ideology limited the role of health consumer
groups to protecting consumer interests in that exchange.
Assured access to the policy table, we believe, weakened the
ability of such groups to autonomously mobilise critical
patient, carer and community opinion. While ‘mainstreaming’
purported to enhance consumer engagement among service
providers and policy makers, it reduced such engagement to
ascertaining the views and experiences of services users, with
users conceived of as individual consumers with, as Judith
Gregory puts it, ‘rights to information, access, choice, and
redress’. In the following article we sketch the metamorphosis
of health politics in Australia from social movement activism
to the co-option of ‘consumers’ as marginal actors within the
policy mainstream. We use the work of John Alford and John
Dryzek to explore how this transformation took place.
John Alford’s influential model explains the health care policy
contest in terms of competing ‘structural interests’—the
professional monopolists, the corporate rationalisers and the
community interest—where typically the community interest
comes to be suppressed. John Dryzek, observing relationships
between governments and social movements, sees that actors
based in civil society ‘sometimes face a choice between action
in the public sphere and action within the state’. Where the
state seeks to exclude social interests, groups have no choice
but to mobilise autonomously outside the state. But where the
state takes an inclusive approach and permeates civil society,
as in Australia, they have a choice to act inside or outside the
state. But acting inside the state does not necessarily ensure
advancement of the aims of a social movement, or indeed
broader democratic objectives. ‘Benign inclusion’ through
co-operative policy-making mechanisms furthers these aims
only if two conditions hold: ‘a group’s defining concern must
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be capable of assimilation to an established or emerging state
imperative [and] civil society’s discursive capacities must not
be unduly depleted by the group’s entry into the state’. Where
a social movement cannot link in with a state imperative, its
inclusion into the state is likely to be largely symbolic and
ultimately detrimental to the vitality of civil society.
Health Activism of the 1960s and 1970s
The struggle for universal health insurance provided a central
focus for health activist groups in the 1960s and 1970s.
Medibank was introduced by the Whitlam government in 1975
following ferocious conflicts with the conservative Opposition,
supported by the Australian Medical Association (AMA).
Medibank marked a watershed in Australian health policy.
Universality and equity in health care became explicit policy
objectives for the first time. As Dick Scotton and Christine
Macdonald note, this program enhanced the power of the
Commonwealth relative to the states over health policy and
weakened ‘the veto power of organised medicine in general,
and the AMA in particular, over the structure of the health
system’. However the hope that breaking the monopoly power
of the medical profession through Medibank would mark an
increase in community influence was soon shown to be ill
founded. The Fraser government dismantled Medibank
through a series of incremental changes, culminating in the
removal of the universal right to free hospital care. The power
had shifted significantly to the state.
Medibank’s successor, Medicare, was introduced by the
Hawke Labor government in 1984. On the face of it the
re-introduction of universal health insurance appeared to be
an expression of social democratic ideology premised on a
conception of consumers as citizens. But this was also the
period in which the NPM was making powerful inroads into
Australian public administration, driving Labor governments
to compromise commitments to democratic participation
implicit in health and other social policy measures. Indeed
Labor governments at federal and state levels were the
principal drivers of a wave of public sector changes in the
1980s and 1990s underpinned by neo-liberal ideology. The
NPM focus on rationality, outcomes, performance measures
and customer satisfaction was consistent with a conception of
the consumer as a market actor exercising individual choice.
As described by Meredith Carter and Debra O’Connor, the
opening up of the health services system to consumer
representatives from the mid-1980s was ‘predicated on the
view that a level of consumer participation is necessary to
ensure appropriate services and products are available in the
marketplace…and to ensure informed consumer choice as to
which services and products best suit the treatment needs
experienced by individuals’.
In Australia as elsewhere health consumer groups first formed
around particular illnesses, with a focus on assisting patients
and their families. A broader consumer organisation, the
Australian Consumers’ Association (today named CHOICE),
which also contributed to the organisation of health
consumers, was formed in 1959. As RobIrvine notes, self-help
activism and critiques of traditional medical authority gained
momentum in the 1970s at the same time as the ‘health
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consumer’ emerged as ‘a central organising principle and
figure of speech’. In this period, reform groups and activists
for the rights of women and the physically and mentally
disabled campaigned vigorously to change norms, practices
and power relationships. The rise of the new, more radical
forms of health activism was intertwined with Labor’s
democratic reform aspirations and, as emphasised, the
ongoing mobilisation for universal health insurance.
Active community participation was advanced by the Whitlam
government through the creation of the Hospitals and Health
Services Commission. The adoption of the recommendations
of the Commission resulted in the extension of
Commonwealth primary care funding to community-managed
health centres, community nurses, regional geriatric and
rehabilitation teams, day hospitals, community mental health
services, women’s health centres and Aboriginal medical
services. Perhaps peripheral when measured against
mainstream health services, one significant result of these
reforms was the emergence of a new sector of local and
regional institutions supported by politicised health
professionals and activists wedded to the ideas and practices
of community health.
Until the mid-1980s at least there was a close relationship
between the community health movement and incipient
health consumer organisations. In Victoria, health and
consumer activists from organisations such as the People’s
Health Collective, the Health Left and Health Feedback Study
Groups, Community Health Action and Information Network,
the Medibank Action Coalition, the Workers Health Action
Group, Women in Industry, Contraception and Health,
Women’s Repetition Injury Support Team, the Women’s
Health Resource Collective and Workers Health Action, came
together in the early 1980s in defence of the community
health program and Medibank. In 1984 the Health Issues
Centre, which today still operates as the de facto Victorian
peak body for health consumer research and advocacy,
emerged from this network of activists.
In the central conflict over universal health insurance,
consumer groups were the natural allies of reform advocates
like the Australian Consumers’ Association, the Australian
Council of Social Services and the Doctors’ Reform Society. In
turn, the Whitlam government made the health policy system
increasingly accessible to such groups. The Fraser government
held back their entry into the mainstream but the process
recommenced with Labor’s return to federal office in 1983 and
around the same time in several of the states. The culmination
of this development was the establishment in 1987 of a peak
organisation, the Consumers Health Forum of Australia
(CHF).
Consumer Health Forum
The government’s intention, as set down in a 1985
Department of Health document was for a consumers’ health
forum to be established as ‘a coalition of community and
consumer groups’ to provide ‘a “community voice” on health
issues’, with the aim of balancing the influence of
well-organised professional and industry groups. It was to be
f d d b  th  D t t b t t  t    i d d t
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funded by the Department but to operate as an independent,
separate, incorporated body. Today the CHF’s membership
encompasses most health consumer groups of significance,
including peak organisations in each state. With around
fifteen full-time staff, it is engaged in submission writing,
workshops and educational initiatives, policy advocacy, and
the publication of newsletters and other publications.
Importantly, it nominates consumer representatives to more
than 150 government, industry, research and professional
committees.
 
The historically blurred lines between the Australian Labor
Party and community activism for universal health insurance,
social equity and a more participatory democracy made the
1980s, when Labor formed government federally and in
several of the states, a period favorable to the inclusion of
consumer groups in health policy. The CHF was established
as the voice of the community with a particular commitment
to preventative and public health and was seen as an
influence that could to some extent counter the power of the
medical profession. Yet, as a government funded entity, it was
from the very outset absorbed into mainstream policy
processes and its independence and critical role was muted.
As noted, the policy influence of the CHF peaked in its first
decade, a period of Labor governments committed to NPM
reforms. As Stephanie Short points out, the CHF’s channelling
of government funding to consumer and community
organisations for autonomous research formed the ‘high water
mark in terms of community participation in the health policy
process’. This program ceased in 1992 when conditions were
tightened for peak health and community organisations. The
government funding the CHF continued to receive was
increasingly targeted to closely audited consultative projects
directed towards government ends rather than autonomous
community development.
The health consumer movement today presents a relatively
cohesive structure through peak bodies at the state level and
the national leadership exercised by the CHF. We have only
fragmentary knowledge of the dynamics of the several
hundred local and state-based groups, which make up the
greater part of health consumer activities, and the extent to
which they exercise influence in health policy. But the formal
consumer presence within the policy system through
organisations such as the CHF does not seem to be sustained
by vigorous or resourceful mobilisation of large numbers of
patients and carers, nor is there a sense of a new generation of
activists following on strongly from those of the 1970s and
1980s. There is no sense of consumer organisations
contributing a strong and distinct voice in the public debate
on health reform. Disease-oriented groups provide much
needed services and support for their particular
constituencies, but typically officials and volunteers are
preoccupied with issues of funding and organisational survival
through government project grants and pharmaceutical
industry funding.
Yet, while the capacity to mobilise autonomously appears to
have been largely drained from the sector, the notion of
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g y ,
‘consumer engagement’ has evolved into a principal objective
in health policy at all levels. But most initiatives that come
under this heading are oriented towards individual service
users or citizens, and the role of consumer organisations tends
to be peripheral at best. Typically their contribution is to
provide representatives for committees and working groups
and to advise on government activities, such as the trials of
deliberative democracy in health policy planning
implemented in Western Australia between 2001 and 2005.
To illustrate this trajectory from vigorous social movement
activism to inclusion into the state we proceed to describe the
role of the CHF in Australian national medicines policy.
Over more than twenty years the CHF and other consumer
groups have issued a stream of reports, proposals, policy
papers and submissions on matters relating to medicines.
These include advertising codes and standards; pharmacy
practices and product information for consumers; quality use
of medicines; and regulatory, access and affordability issues
associated with the Pharmaceutical Benefits Scheme (PBS),
Australia’s tax-financed medicines insurance program.
Medicines Policy
Consumers are represented on most regulatory committees
and working groups in the medicines sector. The
Pharmaceutical Benefits Advisory Committee (PBAC), which
recommends to the Minister for Health which medicines
should be included on the PBS and the conditions for their
listing, is the central node of the regulatory system.
Membership of this committee would seem to suggest a degree
of real influence. Yet, constrained by confidentiality
requirements, consumer representatives on this and other
committees are to all intents and purposes co-opted as
marginal players into a highly complex regulatory system.
Positively, the knowledge gained from participation in
regulatory and advisory committees ensures the availability of
expertise within the consumer movement, but only a small
number of activists are engaged with medicines regulation in
an ongoing basis. Consumer organisations are excluded from
the quasi-secret meetings between government and the
pharmaceutical industry where deliberation occurs on major
policy issues.
When health consumer activists first made medicines policy a
key focus of their activities in the 1980s, they encountered a
great deal of suspicion on the part of the medical profession,
pharmacy retailers and the pharmaceutical industry. But
aversion gradually gave way to acceptance of a legitimate role
for consumer groups in this policy sector. The dominant actors
each recognised that participation by consumer groups in the
policy process provided opportunities for new alliances. The
formation of the CHF brought forth a credible voice in support
of the government on critical aspects of the reform agenda. In
John Alford’s terms, incorporation of the previously excluded
community interest strengthened the position of the corporate
rationalisers. In particular, the pursuit of PBS efficiencies,
notably the introduction of cost effectiveness as a condition for
the government subsidy, was compatible with the social
equity and ‘rational medicines policy’ program of the
arena » Health Activisim to Health ‘Consumers’ http://www.arena.org.au/2011/01/health-activisim-to-health-%e2%80...
5 of 8 1/02/2011 12:04 PM
consumer movement. Similarly there was the beginning of
more cooperative relations between consumer groups and the
pharmaceutical industry. This relationship was subsequently
deepened through, for example, consumer representation on
the industry committee that oversees adherence to a code of
conduct for the ethical marketing and promotion of
prescription pharmaceuticals. Today several pharmaceutical
companies, including Pfizer and GlaxoSmithKline, are
‘corporate members’ of the CHF.
The inclusion of the CHF into a set of ‘partnerships’, within
constraints laid down by the pharmaceutical industry and the
government, is most evident in the development of Australia’s
‘national medicines policy’. The notion of a national
medicines policy derives from the World Health Assembly and
the World Health Organization, in particular its Action
Programme on Essential Drugs established in 1981. It was
envisaged that health policy in all countries would aim to
provide the population with access to appropriately
prescribed, safe, effective and affordable medicines.
Australia’s health ministers in 1988 adopted a series of
general health policy targets in the document Health for all
Australians. This was followed by the Health Ministers’
establishment of the Health Targets and Implementation
(Health for All) Committee. The CHF became a co-opted
member of this committee and was central in ensuring the
committee recommendation that a comprehensive medicinal
drugs policy be adopted. The inclusion of the consumer
movement in this process was partly in recognition of the
intellectual and advocacy work for a national medicines policy
undertaken by the CHF. A model had been presented in a
1988 CHF discussion paper, co-authored by academic John
Braithwaite. Circulated to all relevant interest groups and
obtaining support from many sources, the discussions
triggered by the CHF initiatives paved the way for the de facto
adoption around 1994–1995 of a national medicines policy.
The concept of a national medicines policy has since proven a
durable de facto policy framework and a reference point for
lobbying by all stakeholders. It encompasses four ‘arms’:
timely access to the medicines that Australians need, at a cost
that individuals and the community can afford (provided
through the PBS); medicines that meet appropriate standards
of quality, safety and efficacy; quality use of medicines; and
maintenance of a responsible and viable medicines industry.
The consumer sector has been a particularly prominent driver
of initiatives to meet the third of these objectives, quality use
of medicines (QUM).
The limits on the influence of the consumer movement are
also discernible in this analysis. Participation in a wide range
of co-operative arrangements has not strengthened the
capacity and inclination of health consumer groups to
mobilise autonomously for democratisation of health services
and policy. The national medicines policy was not achieved
principally as a result of CHF lobbying, and much less
through the mobilisation of its member organisations and
supporters. For the pharmaceutical industry the national
medicines policy process, as noted, provided the opportunity
to gain acceptance for the objective of a ‘viable pharmaceutical
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industry’, with implications for the operation of PBS pricing
arrangements. That the initial misgivings of industry about
the national medicines policy could be overcome is due to the
convergence of industry and government interests. In short,
although the consumer movement has won an established
place in this policy arena, the limited influence it has gained
does not pose a challenge to the power of the dominant actors.
State Imperatives and Structural Interests
While no theory provides a full explanation of the
metamorphoses of the role of health consumer groups, we
believe Alford’s ‘structural interest’ analysis and Dryzek’s
concept of ‘state imperatives’ shed light on them. The
influence of community and consumer groups in health policy
has varied with the objectives pursued, at different times, by
the ‘corporate rationalisers’, but also with the broader ‘state
imperatives’ of the government of the day. As activist groups
born of the wider social movements of the 1960s and 1970s,
these organisations have continued to lend vital support to
the Labor party in the perennial political contest over
universal health insurance. The establishment of Medibank,
which weakened the monopoly power of the medical
profession, was a limited measure of their success in
mitigating the medical dominance of health policy and
practice and in opening the door, to some extent, to
democratic participation in health policy. Their accessing of
the power of the state, however, exposed consumer groups to
the forces driving and constraining that power.
When corporate rationalisers in periods of Labor government
were concerned with the state’s legitimation imperative of
popular support for health services reform, the democratising
efforts of activist groups were encouraged and their policy role
embraced. But when governments shifted to a focus on
efficiency and economic and managerial objectives rather
than democracy, community activist groups came under
pressure to redefine their role more narrowly in accordance
with neo-liberal and managerialist paradigms. Having long
accepted their designation as ‘consumer groups’, they
tempered their commitment to radical reform of the health
system in favour of participation in the mainstream policy
process.
Consumer groups have continued to play a role in preserving
an important democratic achievement: universal health
insurance. They can also boast significant achievements in
representing consumer interests on many other issues,
including in relation to the national medicines policy. But we
cannot fail to observe the negative effects on the autonomy
and vitality of such groups of having gained entry into the
state and a degree of influence, albeit severely constrained, on
government policy. Co-option, while assuring entry to the
policy mainstream, marginalises their capacity for mobilising
health services users, and citizens more broadly.
This is an edited and abbreviated version of a chapter
in Lofgren, H. & E. de Leeuw & M. Leahy (eds)
Democratising Health: Consumer Groups in the
Policy Process (Edward Elgar, forthcoming 2011). This
book examines the role of consumer organisations in
health policy across a number of countries in Europe,
N th A i  d A i  F   i f ti  t t
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North America and Asia. For more information, contact
hans.lofgren@deakin.edu.au
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